Duff & Phelps Investment Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-7,640
Closed -$759K 224
2019
Q3
$759K Hold
7,640
0.01% 192
2019
Q2
$706K Buy
7,640
+210
+3% +$19.9K 0.01% 216
2019
Q1
$701K Hold
7,430
0.01% 212
2018
Q4
$476K Hold
7,430
0.01% 218
2018
Q3
$665K Sell
7,430
-720
-9% -$63.6K 0.01% 212
2018
Q2
$647K Sell
8,150
-230
-3% -$19.1K 0.01% 219
2018
Q1
$748K Sell
8,380
-210
-2% -$20.2K 0.01% 214
2017
Q4
$896K Sell
8,590
-200
-2% -$22.6K 0.01% 211
2017
Q3
$1.28M Sell
8,790
-20
-0.2% -$2.72K 0.02% 197
2017
Q2
$1.14M Sell
8,810
-600
-6% -$73.5K 0.02% 201
2017
Q1
$1.17M Sell
9,410
-150
-2% -$18K 0.02% 204
2016
Q4
$1.11M Sell
9,560
-240
-2% -$26.7K 0.02% 207
2016
Q3
$1.02M Sell
9,800
-350
-3% -$37.9K 0.01% 205
2016
Q2
$1M Sell
10,150
-300
-3% -$31K 0.02% 191
2016
Q1
$1.05M Sell
10,450
-2,570
-20% -$265K 0.02% 187
2015
Q4
$1.56M Sell
13,020
-620
-5% -$71.7K 0.03% 176
2015
Q3
$1.48M Sell
13,640
-760
-5% -$94.3K 0.02% 177
2015
Q2
$1.67M Hold
14,400
0.03% 180
2015
Q1
$1.66M Buy
+14,400
New +$1.72M 0.02% 181

Other funds holding CELG

Duff & Phelps Investment Management's CELG Position: Q4 2019 in Review

Duff & Phelps Investment Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 7,640 shares — an estimated $759K sold.

Duff & Phelps Investment Management first reported a position in CELG in Q1 2015 and held it in 19 quarters. The position peaked at $1.67M in Q2 2015. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Duff & Phelps Investment Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Duff & Phelps Investment Management sold 7,640 Celgene Corp shares in Q4 2019, an estimated $759K.
  • Duff & Phelps Investment Management first reported a position in Celgene Corp in Q1 2015 and held it in 19 quarters.
  • Duff & Phelps Investment Management's Celgene Corp position peaked at $1.67M in Q2 2015.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Duff & Phelps Investment Management's 13F filing for Q4 2019, filed 24 Jan 2020.